Certara, a provider of decision support technology and consulting services specialising in drug development and healthcare, has announced that it has established two Phoenix Centers of Excellence in Asia
Optibrium and The Edge Software Consultancy, developers of software products and services for drug discovery and development, have announced a collaboration to provide an integrated platform linking the StarDrop and BioRails software packages
Helix Nebula – The Science Cloud (HNSciCloud) – has launched a €5.3 million tender to establish a European hybrid cloud platform
MSC Software has announced a partnership with the Campania Region Technological Aerospace District to launch the SIMULAB Project
Certara, a provider of decision support technology and consulting services for optimising drug development, has announced that Mitsubishi Tanabe has joined its Simcyp Consortium and licensed its proprietary Simcyp Population-based Simulator
Dassault Systèmes, a provider of product lifecycle management solutions, has announced that it will acquire Computer Simulation Technology, a specialist in electromagnetic and electronics simulation, for approximately 220 million euros
A new bioinformatics company, Nostrum BioDiscovery, a spin-out created through the combined efforts of The Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Center - National Supercomputing Center (BSC-CNS) – has been created accelerate drug discovery through the application of high-performance computing
DataDirect Networks (DDN), has opened a research and development centre in Paris, in response to strong demand the French market and across Europe for high-performance big data storage solutions
Computer Simulation Technology has announced the acquisition of IdemWorks, a provider of modelling tools and services
The Pistoia Alliance has announced that the Presidents Challenge 2016 is now open for entries. The deadline for entries is Friday 2 September
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
